CTRI/2023/10/059270招募中4 期
Donor-derived circulating cell free DNA as a rejection bio-marker and modulator of immunosuppression following liver transplantation: A randomized controlled trial. - NI
Amrita institute of medical sciences and research0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All Pts admitted to undergo live donor liver transplantation
排除标准
- •1.Multi-organ transplant recipients
- •2.Those who have undergone dual organ transplant from a single donor
- •3.Identical twin donor and recipient
- •4.Pregnant women
- •5.Patients with leukopenia, leukocytosis & inflammatory illness.
- •6.Patients who have undergone blood transfusions in the past one month.
- •7.Those who undergo regular & strenuous physical activity
- •8.Pts with symptoms of hematoma
- •9.Pts with middle hepatic venous thrombosis
研究者
相似试验
尚未招募
不适用
Circulating cell free DNA: the fingerprint of the PlacentaPlacental disease10035129NL-OMON56768Erasmus MC, Universitair Medisch Centrum Rotterdam50
尚未招募
不适用
Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapymalignant tumorJPRN-UMIN000003715Yokohama City University, School of Medicine30
尚未招募
不适用
Clinical validation of circulating cell free DNA [ccfDNA] as a biomarker of metabolic healthObesityACTRN12622001326785Commonwealth Scientific and Industrial Research Organisation100
已完成
不适用
forecasting capacity of Circulating Free DNA to assess treatment results in Patients with Oral CancerCTRI/2019/03/018136RMLIMS30
Unknown
不适用
Non Invasive Blood Test To Diagnose Acute Rejection After Kidney TransplantationKidney Transplant RecipientsNCT02424227CareDx401